ONE YEAR ENDOSCOPIC AND HISTOLOGIC OUTCOMES TO TOFACITINIB THERAPY IN REFRACTORY ULCERATIVE COLITIS

被引：0
|
作者：
Verstockt, Bram
Alsoud, Dahham
Outtier, An
Sabino, Joao
Vermeire, Severine
De Hertogh, Gert
Ferrante, Marc
机构：
来源：
GASTROENTEROLOGY | 2021年 / 160卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su462
引用
收藏
页码：S702 / S702
页数：1
相关论文
共 50 条
  • [21] One-year experience with ustekinumab in therapy-refractory or -intolerant patients with ulcerative colitis
    Ochsenkhn, T.
    Tillack, C.
    Schnitzler, F.
    Szokodi, D.
    Janelidze, S.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S298 - S299
  • [22] Effects of Ustekinumab (UST) Induction Therapy on Endoscopic and Histologic Healing in Ulcerative Colitis
    Marone, Colleen
    Li, Katherine
    Friedmae, Joshua R.
    Zhang, Hongyan
    Yang, Feifei
    FeagaM, Brian G.
    Peyrin-Biroulet, Laurent
    De Hertogh, Gert
    SWISS MEDICAL WEEKLY, 2019, : 27S - 27S
  • [23] Efficacy of High Dose Tofacitinib in Refractory Ulcerative Colitis Patients
    Ansari, Usman S.
    Abraham, Bincy P.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S323 - S324
  • [24] Refractory pediatric ulcerative colitis responding to high dose tofacitinib
    Miyata, Eri
    Arai, Katsuhiro
    Takeuchi, Ichiro
    Shimizu, Hirotaka
    Shimizu, Toshiaki
    PEDIATRICS INTERNATIONAL, 2023, 65 (01)
  • [25] Tofacitinib for the treatment of acute severe ulcerative colitis refractory to infliximab
    Fortuny Bauza, Marta
    Canete Pizarro, Fiorella
    Calm Salvans, Anna
    Calafat Sard, Margalida
    Domenech Morral, Eugeni
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2022, 45 : 11 - 12
  • [26] Pregnancy Outcomes in the Tofacitinib Ulcerative Colitis OCTAVE Studies
    Mahadevan, Uma
    Baumgart, Daniel C.
    Dubinsky, Marla C.
    Lawendy, Nervin
    Friedman, Gary S.
    Konijeti, Gauree G.
    Groechenig, Hans P.
    Jones, Thomas V.
    Marren, Amy
    Thorpe, Andrew J.
    Nduaka, Chudy I.
    Su, Chinyu
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S410 - S411
  • [27] EFFICIENCY OF DUAL THERAPY WITH VEDOLIZUMAB AND TOFACITINIB IN REFRACTORY ULCERATIVE COLITIS PATIENTS - SINGLE CENTRE EXPERIENCE
    Kolar, Martin
    Kastylova, Kristyna
    Lukas, Martin
    Duricova, Dana
    Hruba, Veronika
    Machkova, Nadezda
    Cerna, Karin
    Jirsa, Jakub
    Kubickova, Kristyna
    Vojtechova, Gabriela
    Lukas, Milan
    GASTROENTEROLOGY, 2023, 164 (04) : S100 - S100
  • [28] EFFICIENCY OF DUAL THERAPY WITH VEDOLIZUMAB AND TOFACITINIB IN REFRACTORY ULCERATIVE COLITIS PATIENTS - SINGLE CENTRE EXPERIENCE
    Kolar, Martin
    Kastylova, Kristyna
    Lukas, Martin
    Duricova, Dana
    Hruba, Veronika
    Machkova, Nadezda
    Cerna, Karin
    Jirsa, Jakub
    Kubickova, Kristyna
    Vojtechova, Gabriela
    Lukas, Milan
    INFLAMMATORY BOWEL DISEASES, 2023, 29 : S78 - S78
  • [29] Tofacitinib Salvage Therapy for Children Hospitalized for Corticosteroid- and Biologic-Refractory Ulcerative Colitis
    Constant, Brad D.
    Baldassano, Robert
    Kirsch, Jacqueline
    Mitchel, Elana B.
    Stein, Ronen
    Albenberg, Lindsey
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2022, 75 (06): : 724 - 730
  • [30] Success of Cyclosporin and Tofacitinib Combination Therapy in a Patient With Severe Steroid-refractory Ulcerative Colitis
    Yang, Qinglu
    Chen, Liang
    Feng, Lijin
    Liu, Changqin
    Fang, Leilei
    Liu, Zhanju
    Sun, Xiaomin
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (12) : E157 - E158
12345